MARIA RODRIGUEZ: Open Payments
NPI 1447892898 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 36 payments from 11 companies in 2025. Trend: 2023 $1,543 · 2024 $708 · 2025 $882
Food & beverage: $814Education: $68
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 15 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $207 |
| AstraZeneca Pharmaceuticals LP | 2 | $94 |
| Janssen Biotech, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| UROGEN PHARMA, INC. | 2 | $49 |
| PFIZER INC. | 2 | $43 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| IMMUNITYBIO, INC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Xtandi, Nubeqa, LYNPARZA, ERLEADA, PLUVICTO, PROVENGE, ZUSDURI, JELMYTO.
Industry payments across TX — which companies pay providers there.
